Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The association between mutations and comorbidities in patients with MDS

Guillermo Garcia-Manero, MD, University of Texas MD Anderson Cancer Center, Houston, TX, outlines the major causes of death in patients with low-risk myelodysplastic syndromes (MDS) and discusses the correlation between specific mutations and comorbidities in patients with MDS. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.